Impact of circulating tumor cell (CTC) nucleus size on outcomes with abiraterone acetate (AA) therapy in men with metastatic castration-resistant prostate cancer (mCRPC).

David Gill, Archana M. Agarwal, Andrew W. Hahn et al.|Journal of Clinical Oncology|2017

Cited by 4